ERT Showcases Scientific and Technological Expertise in Improving Clinical Research at DIA Annual Meeting
Summary
ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced its scientific and technological experts will present a series of innovative and educational live sessions and posters at the 2019 Drug Information Association (DIA) Annual Meeting in San Diego, June 23-27. ERT’s industry-recognized thought leaders will share their knowledge on the collection of high-quality patient safety and efficacy data and the use of novel technologies for improving clinical research during the following podium presentations: Additional topics being presented by ERT scientists during the poster sessions on June 25 and 26 include: DIA attendees can visit booth #1231 for information on how ERT’s analytics, data, and technology solutions minimize risk and help trial sponsors accelerate clinical development. With nearly 50 years of clinical and therapeutic experience, ERT balances knowledge of what works with a vision for what’s next, so it can adapt without compromising standards. Pharma companies, biotechs and CROs have relied on ERT solutions across 15,000 studies, spanning more than four million patients to date. By identifying trial risks before they become problems, ERT enables customers to bring clinical treatments to patients quickly ─ and with confidence.
Classifications
AskAI Classifications
LabelsLinked Companies
